424 related articles for article (PubMed ID: 15063832)
1. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
2. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
Williams SP; Dorn GW; Rapoport RM
Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
[TBL] [Abstract][Full Text] [Related]
5. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
7. Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide.
Kemp BK; McPherson GA
Eur J Pharmacol; 1998 Aug; 354(2-3):173-8. PubMed ID: 9754918
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
9. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
Tosun M; Paul RJ; Rapoport RM
Eur J Pharmacol; 1997 Dec; 340(2-3):203-8. PubMed ID: 9537816
[TBL] [Abstract][Full Text] [Related]
11. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
12. Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro.
Cocks TM; King SJ; Angus JA
Br J Pharmacol; 1990 Jun; 100(2):375-8. PubMed ID: 2143093
[TBL] [Abstract][Full Text] [Related]
13. The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro.
O'Brien AJ; Thakur G; Buckley JF; Singer M; Clapp LH
Br J Pharmacol; 2005 Feb; 144(3):367-75. PubMed ID: 15655519
[TBL] [Abstract][Full Text] [Related]
14. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
15. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform.
Errasti AE; Luciani LI; Cesio CE; Tramontano J; Boveris D; Daray FM; Nowak W; Pelorosso FG; Rothlin RP
Eur J Pharmacol; 2007 May; 562(3):227-35. PubMed ID: 17362923
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide inhibits hypoxic relaxation of isolated porcine coronary arteries under conditions of impaired glycolysis.
Mellemkjaer S; Nielsen-Kudsk JE
Eur J Pharmacol; 1994 Aug; 270(4):307-12. PubMed ID: 7805779
[TBL] [Abstract][Full Text] [Related]
18. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
Sessa WC; Halushka PV; Okwu A; Nasjletti A
Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.
Hecker M; Bara AT; Bauersachs J; Busse R
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):407-14. PubMed ID: 7738833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
